Tissue-Based PD-L1 Expression Is the Strongest Predictor of Overall Survival Benefit From ICI in Advanced Gastroesophageal Cancer-Reply. Yoon HH, Shi Q, Ajani JA. JAMA Oncol 2023;9:280-281.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yoon HH, Shi Q, Ajani JA. Tissue-Based PD-L1 Expression Is the Strongest Predictor of Overall Survival Benefit From ICI in Advanced Gastroesophageal Cancer-Reply. JAMA Oncol 2023;9:280-281.
PMID: 36547945